Immediate Impact
7 standout
Citing Papers
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
2023 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
Works of É. Lagneau being referenced
Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study
2019
Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| É. Lagneau | 156 | 7 | 27 | 212 | 160 | 15 | 376 | |
| Lucianna Sparano | 73 | 15 | 216 | 119 | 13 | 389 | ||
| H Tobon | 63 | 57 | 172 | 48 | 15 | 367 | ||
| Dvora Cyrlak | 68 | 50 | 161 | 76 | 13 | 336 | ||
| Stavros N Georgiannos | 144 | 21 | 99 | 62 | 13 | 412 | ||
| Edward J. Tabah | 179 | 2 | 7 | 138 | 41 | 11 | 377 | |
| Alisa C. Thorne | 31 | 6 | 17 | 110 | 46 | 14 | 350 | |
| Maria Grazia Cattani | 32 | 28 | 246 | 142 | 13 | 363 | ||
| Erjiang Tang | 111 | 1 | 19 | 140 | 37 | 22 | 352 | |
| Fatma Paksoy Türköz | 133 | 1 | 20 | 81 | 37 | 19 | 450 | |
| Michael L. Palmer | 118 | 20 | 112 | 39 | 17 | 446 |
All Works
Loading papers...